David Landman, MD
Tel: (718) 270-3790 • Fax: (718) 270-1390
SUNY Downstate Medical Center
450 Clarkson Avenue, Box 77
Brooklyn, NY 11203
Molecular epidemiology of MDR Gram negative bacterial pathogens
Education and Training:
- Residency: SUNY Downstate 1984
- ID Fellowship: SUNY Downstate 1987
Why I enjoy working at SUNY Downstate:
Interesting pathology, teaching and research
- Landman D, Urban C, Backer M, Kelly P, Shah N, Babu E, Bratu S, Quale J. Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity. J Clin Microbiol 2010; 48: 4604-7.
- Landman D, Kelly P, Backer M, Babu E, Shah N, Bratu S, Quale J. Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother 2011;66:332-4.
- Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, Landman D, Bratu S, Augenbraun M, Quale J. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2009 May;30(5):447-52.
- Bratu S, Landman D, George A, Salvani J, and Quale J. Correlation of the Expression of acrB and the Regulatory Genes marA, soxS, and ramA with Antimicrobial Resistance in Clinical Isolates of Klebsiella pneumoniae Endemic to New York City. J Antimicrob Chemother 2009; 64:278-83.
- Landman D, Bratu S, and Quale J. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 2009; 58:1303-8.